New data reveals a rising trend in generalized anxiety disorder (GAD) prevalence among U.S. adults, emphasizing the need for improved diagnosis and treatment. It was found that more than one in ten ...

Occasionally worrying about an upcoming work presentation, a stressful family situation, or a complicated relationship is a natural part of life. But when that worry becomes excessive, frequent, and ...

In the mental health field, we tend to pathologize and diagnose even commonly encountered challenges. Through the lens of human experience, however, we can recognize that some emotional and mental ...

Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...

Anxiety is the body's natural response to stress, but some people have an anxiety disorder with excessive fear or worry that ...

All adults under age 65 should be screened for anxiety, according to the influential US Preventive Services Task Force, which issued new draft guidelines last month. The guidelines, which help guide ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

Many of us overtalk, for instance, when we’re socially anxious or deeply interested in a topic. At other times, we’re baffled by people who repeatedly monopolize conversations. Rarely, though, do we ...

A new Cochrane review confirmed that antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), are superior to placebo in ...